Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Sep, 11 2025
Dec, 24 2025
Sep, 24 2025
May, 23 2025
Sep, 28 2025